IPHA
Innate Pharma·NASDAQ
--
--(--)
--
--(--)
IPHA fundamentals
Innate Pharma (IPHA) expects to report earnings on Nov 14, 2022, with estimated revenue of -- (YoY 0.00%), and EPS at -- (YoY 0.00%).
Revenue estimate / YoY
--
0.00%
EPS estimate / YoY
--
0.00%
Report date
Nov 14, 2022
EPS
Revenue
Revenue & Expenses
Key Indicators
Innate Pharma (IPHA) key financial stats and ratios, covering profitability, financial health, and leverage.
Innate Pharma (IPHA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Innate Pharma (IPHA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Innate Pharma (IPHA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Innate Pharma (IPHA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Innate Pharma (IPHA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Innate Pharma beat or miss consensus estimates last quarter?What is Innate Pharma's gross profit margin?What were the key takeaways from Innate Pharma's earnings call?What does Innate Pharma do and what are its main business segments?What is the market's earnings forecast for Innate Pharma next quarter?What guidance did Innate Pharma's management provide for the next earnings period?What factors drove the changes in Innate Pharma's revenue and profit?What were the key takeaways from Innate Pharma’s earnings call?
